LeMaitre Vascular LMAT reported its Q1 earnings results on Tuesday, May 2, 2023 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
LeMaitre Vascular beat estimated earnings by 8.0%, reporting an EPS of $0.27 versus an estimate of $0.25.
Revenue was up $7.51 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 4.29% increase in the share price the next day.
Here's a look at LeMaitre Vascular's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.26 | 0.28 | 0.26 | 0.28 |
| EPS Actual | 0.25 | 0.25 | 0.29 | 0.27 |
| Revenue Estimate | 40.99M | 40.06M | 41.45M | 38.75M |
| Revenue Actual | 40.95M | 39.03M | 42.11M | 39.56M |
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.26 | 0.28 | 0.26 | 0.28 |
| EPS Actual | 0.25 | 0.25 | 0.29 | 0.27 |
| Revenue Estimate | 40.99M | 40.06M | 41.45M | 38.75M |
| Revenue Actual | 40.95M | 39.03M | 42.11M | 39.56M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
LeMaitre Vascular management provided guidance for FY 2023, expecting earnings between $1.14 and $1.28 per share.
To track all earnings releases for LeMaitre Vascular visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.